EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Effects of Prebiotics and Probiotics on Symptoms of Depression and Anxiety in Clinically Diagnosed Samples: Systematic Review and Meta-analysis of Randomized Controlled Trials

Wirkung von Präbiotika und Probiotika auf Depressions- und Angstsymptome bei klinisch diagnostizierten Stichproben: systematische Übersicht und Metaanalyse randomisierter kontrollierter Studien

Afrida Asad, Megan Kirk iD, Sufen Zhu, Xue Dong iD, Min Gao iD

Nutrition Reviews · 01.07.2025 · 83 (7) · e1504-e1520

DOI: 10.1093/nutrit/nuae177 ↗

Auf einen Blick

23 RCTs mit 1401 Patient:innen wurden ausgewertet. Probiotika waren mit weniger Depressions- und Angstsymptomen verbunden; Präbiotika zeigten keinen signifikanten Effekt auf Depression.

Fragestellung

Wirken Präbiotika, Probiotika und Synbiotika bei klinisch diagnostizierten Patient:innen gegen Depressions- und Angstsymptome?

Methode

Systematische Suche in Embase, Medline, PsycINFO, CINAHL, Cochrane Library und Science Citation Index bis 22. Mai 2023; random-effects-Metaanalyse von RCTs; Cochrane Risk of Bias.

Ergebnisse

23 RCTs mit 1401 Patient:innen; 20 Studien in der Metaanalyse. Probiotika: Depression SMD –0,96 (95 %-KI –1,31 bis –0,61), Angst SMD –0,59 (95 %-KI –0,98 bis –0,19). Präbiotika: Depression SMD –0,28 (95 %-KI –0,61 bis 0,04).

Einschränkungen

Hohe Heterogenität zwischen den Studien; Subgruppenanalysen zeigten Beiträge von Studiendauer und Probiotika-Formulierungen zur Varianz.

Schlussfolgerung der Autor:innen

Probiotika zeigten ausgeprägte Reduktionen von Depressionssymptomen und moderate Reduktionen von Angstsymptomen. Präbiotika zeigten einen nicht signifikanten Trend zur Reduktion von Depression.

Kernaussagen

  • Probiotika senkten Depressionssymptome: SMD –0,96 (95 %-KI –1,31 bis –0,61)
  • Probiotika senkten Angstsymptome: SMD –0,59 (95 %-KI –0,98 bis –0,19)
  • Präbiotika zeigten für Depression keinen signifikanten Effekt

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Systematische Übersicht in der Zeitschrift Nutrition Reviews, online erschienen am 28.12.2024. Verfasst von Afrida Asad und 4 weiteren Autor:innen. Beteiligte Einrichtung: Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, United Kingdom. Hauptthemen laut MEDLINE: Probiotics, Prebiotics, Depression, Anxiety. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care Research, Oxford Health Biomedical Research, Department of Health and Social Care.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

The use of prebiotics and probiotics as a treatment for psychiatric conditions has gained interest due to their potential to modulate the gut–brain axis. This review aims to assess the effectiveness of these interventions in reducing symptoms of depression and anxiety in psychiatric populations.

Objective

The aim was to comprehensively review and appraise the effectiveness of prebiotic, probiotic, and synbiotic interventions in reducing clinical depression and anxiety symptoms. Data Sources Systematic searches were conducted across Embase, Medline, PsycINFO, CINAHL, Cochrane Library, and Science Citation Index from database inception to May 22, 2023. Data Extraction Randomized controlled trials investigating prebiotic, probiotic, or synbiotic interventions for treating clinical depression or anxiety symptoms in clinical samples were included. Data were extracted on study characteristics, intervention details, and outcome measures. The Cochrane Collaboration Tool was used to assess the risk of bias. Data Analysis The standardized mean difference (SMD) was calculated using Hedge’s g as the metric of effect size. A random-effects model was applied to estimate pooled effect sizes with 95% CIs. Subgroup analyses were performed based on study characteristics, methodological factors, and intervention types. Sensitivity analyses excluded studies with a high risk of bias.

Results

Twenty-three RCTs involving 1401 patients met the inclusion criteria, with 20 trials providing sufficient data for meta-analysis. Of these, 18 trials investigated probiotics for depression, 9 trials assessed probiotics for anxiety, and 3 trials examined prebiotics for depression. Probiotics demonstrated a significant reduction in depression symptoms (SMD: –0.96; 95% CI: –1.31, –0.61) and a moderate reduction in anxiety symptoms (SMD: –0.59; 95% CI: –0.98, –0.19). Prebiotics did not show a significant effect on depression (SMD: –0.28; 95% CI: –0.61, 0.04). High heterogeneity was observed across studies, and subgroup analyses indicated that study duration and probiotic formulations contributed to the variation in effect sizes.

Conclusion

Probiotics showed substantial reductions in depression symptoms and moderate reductions in anxiety symptoms. Prebiotics showed a nonsignificant trend toward reducing depression. An adjunctive mental health treatment approach that diagnoses, monitors, and treats the gut microbiome alongside traditional pharmacological treatment holds promise for clinical practice. Systematic Review Registration PROSPERO registration no. CRD42023424136.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsPrebioticsDepressionAnxietyHumansRandomized Controlled Trials as TopicSynbiotics

Stichwörter der Autor:innen

anxietydepressionmeta-analysisprebioticsprobiotics

Substanzen

Prebiotics

Autor:innen und Institutionen

  • Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, United Kingdom.
  • Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, United Kingdom.
  • NIHR Oxford Health Biomedical Research Centre, Warneford Hospital, Oxford OX3 7JX, United Kingdom.

ORCID-Profile: Megan Kirk, Xue Dong, Min Gao

Förderung

  • National Institute for Health and Care Research
  • Oxford Health Biomedical Research
  • Department of Health and Social Care

Zitieren

APA

Asad, A., Kirk, M., Zhu, S., Dong, X., & Gao, M. (2025). Effects of Prebiotics and Probiotics on Symptoms of Depression and Anxiety in Clinically Diagnosed Samples: Systematic Review and Meta-analysis of Randomized Controlled Trials. Nutrition Reviews, 83(7), e1504-e1520. https://doi.org/10.1093/nutrit/nuae177

Vancouver

Asad A, Kirk M, Zhu S, Dong X, Gao M. Effects of Prebiotics and Probiotics on Symptoms of Depression and Anxiety in Clinically Diagnosed Samples: Systematic Review and Meta-analysis of Randomized Controlled Trials. Nutrition Reviews. 2025;83(7):e1504-e1520. doi:10.1093/nutrit/nuae177

BibTeX
@article{Asad2025,
  author = {Asad, Afrida and Kirk, Megan and Zhu, Sufen and Dong, Xue and Gao, Min},
  title = {Effects of Prebiotics and Probiotics on Symptoms of Depression and Anxiety in Clinically Diagnosed Samples: Systematic Review and Meta-analysis of Randomized Controlled Trials},
  journal = {Nutrition Reviews},
  year = {2025},
  volume = {83},
  number = {7},
  pages = {e1504--e1520},
  doi = {10.1093/nutrit/nuae177}
}
Kostenlos starten →